Exagen Inc.XGNNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank5
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P5
Near historical low
vs 3Y Ago
-14.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-202.34%
Q3 2025202.05%
Q2 202572.96%
Q1 2025-3039.67%
Q4 2024116.68%
Q3 202410.31%
Q2 202473.16%
Q1 2024-208.28%
Q4 2023387.10%
Q3 202371.36%
Q2 2023-4.15%
Q1 2023-70.02%
Q4 202214.19%
Q3 202240.09%
Q2 2022-30.09%
Q1 2022-41.79%
Q4 2021-10.75%
Q3 2021-22.70%
Q2 2021-3.20%
Q1 2021-10.59%
Q4 2020-83.22%
Q3 202055.26%
Q2 2020-44.08%
Q1 202015.94%
Q4 2019-135.71%
Q3 201923.15%
Q2 2019-11.18%
Q1 2019-4.33%
Q4 20187.66%
Q3 2018-2.33%
Q2 201842.33%
Q1 20180.00%
Q4 2015-16.60%
Q3 2015-1.72%
Q2 2015-2.63%
Q1 2015-13.63%
Q4 2014-2.39%
Q3 201413.14%
Q2 201414.08%
Q1 2014-41.15%